UDOPAL Study: Home-Based Interventional Approach to Pain Management in Home-Hospitalized Patients
- Sponsor
- Hospital de Manises
- Study ID
- NCT07265492
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cancer Pain
- Chronic Pain
- Neuropathic Pain
- Palliative Care
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- UDOPAL model — OTHERThe UDOPAL model proposes a novel clinical approach to manage pain in patients hospitalized at home through the use of interventional pain techniques. The model enables trained home-hospitalization professionals to perform minimally invasive, ultrasound-guided procedures at the patient's home when conventional pharmacological strategies are insufficient. This observational study evaluates the feasibility, safety, and clinical effectiveness of this innovative home-based pain management approach, focusing on pain intensity reduction, opioid-sparing effect, improvement in functional status, and patient and family satisfaction.
Study Details
The UDOPAL Study proposes an innovative home-based care approach for the management of pain in patients admitted to the Home Hospitalization Unit (UHD). This model incorporates interventional pain management techniques into the clinical practice of home-hospital professionals, supported when necessary by specialists from the Pain Medicine Unit. Pain is a prevalent and often undertreated problem in patients receiving home hospitalization, where complex or oncologic pain may require specialized procedures that traditionally are only performed in hospital settings. The UDOPAL model aims to bridge this gap by providing ultrasound-guided and minimally invasive pain procedures directly at the patient's home, including nerve blocks, infiltrations, and other targeted interventions. This observational, prospective study evaluates the feasibility, safety, and clinical impact of implementing interventional pain management at home. Adult patients with chronic, oncologic, or complex pain will be included. Outcomes include pain intensity, opioid use, functional improvement, quality of life, and patient satisfaction, as well as adverse events related to the techniques. The study seeks to provide scientific evidence supporting a new model of interventional home-based pain care that improves comfort, continuity of care, and efficient use of healthcare resources. The project was approved by the Ethics Committee (CEIm Hospital Universitario y Politécnico La Fe, Acta No. 600, 08/10/2025) and is conducted at Hospital de Manises (Valencia, Spain).
Key Dates
- First listed
- Dec 4, 2025
- Start date
- Dec 1, 2025
- Status verified
- Nov 2025
- Primary completion
- Oct 8, 2026
- Completion
- Oct 8, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: UDOPAL Cohort Description: Prospective observational cohort including patients admitted
Primary Outcome Measure
Change in Pain Intensity (Numeric Rating Scale, NRS 0-10) [ Time Frame: Baseline (Day 0), 24 hours, 48 hours, 1 week, 1 month, and at discharge from the Home Hospitalization Unit (HHU) ]
Central Contacts
- Estefanía Romero-Serrano, MD, PhD, EDAIC961 84 50 00
Related Studies
- Resiniferatoxin to Treat Severe Pain Associated With Advanced CancerPHASE1 · Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone PainPHASE1/PHASE2 · Not Yet Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Comparing the Stanford Letter Project Form to Traditional Advance DirectivesRecruiting · Stanford University · Stanford, California